คู่มือการใช้โปรแกรม Pharmacy MTM

! "#$%&'()*'+#,-.+/01)2"$2342,5,$67)(%84094' :);+5,$<#,=#>3?0#@AB6C,DE=($'"#$$67)(%84094',);, /CF,>E#4
1G>)H*D."#$79ABI9<%JE=.=D#+*D./,KL.+:ML4M0#E6N$>C$K.4M"#$52<=#$6=6=#E "#$4M-<.49B-.+I9<%JE=/(K;.+*<, %$6E)*'-.+"#$$)"O#
@P*'"$$413-0#@ $#="#$=#AB6"#$52<=# =D.4/%Q,%$6N=2,R*D."#$79ABI9<%JE= N7=43D+CE)+/%S#C4#=-.+"#$$)"O#/@KL./@'L4
>3?0#@2ME'*-.+I9<%JE=,);,/.+
!
! 14#>4/01)2"$$42342, (%$6/:TU:=) /CF,>E#41G>)H-.+-<.49B5,"#$79ABI9<%JE=N7=/V@#6"#$52<=# WX+4M"#$
@)Y,#N%$A"$4"#$($'C#$W)7"#$7<#,=# (Community Pharmacy MTM) ZXL+$)("#$1,)(1,3,W#" 1G,)"+#,CB)"%$6"),
13-0#@ACD+2#*' /-* 13 "$3+/:@4C#,>$ /@KL./%Q,"#$W)7/"F(-<.49B.=D#+/%Q,$6((N7=,GCB)""#$-.+"#$($'C#$W)7"#$7<#,
=# (Medication Therapy Management: MTM) 4#/%Q,A,E:#+-.+"#$@)Y,#N%$A"$4ZXL+%$6".(7<E= -<.49B:)LEU%-.+I9<
%JE= %$6E)*'"#$$)"O# $#=B6/.M=7"#$52<=#5,A*DB6>$);+ "#$><,C#%[HC#W#""#$52<=# (Drug Related Problems: DRPs)
"#$(),:X">D#W#"C<.+%&'()*'"#$ "#$*$EW>E#4$9<1X"/:<# "#$(),:X"-<.49B"#$1D+*D.-.+I9<%JE=N7=1#4#$@'4@R$#=+#,IB
1GC$)("#$@)Y,#$6=6:ML 1 AB61DE,$6=6:ML 2 /%Q,"#$@)Y,#$6(("#$/2KL.4*D.-<.49B/>$K.-D#=ID#,$6((:#+U"B /@KL.1$<#+
$6(("#$79ABI9<%JE=*D./,KL.+7<#,($'C#$W)7"#$7<#,=#5C</C4#614AB6%B.70)=*D.I9<%JE=
!
! N%$A"$4"#$($'C#$W)7"#$7<#,=# (Community Pharmacy MTM) ,M; U7<$)(>G%$X"O#.=D#+*D./,KL.+W#"
IT.0H.7$. $3D+/@F2$ 1"3B(G$3+T'B%] >?6/01)2T#1*$R W3^#B+"$?R4C#E':=#B)= AB6$6((1#$1,/:T@)Y,#N7= 0". "PO?R
/IK.">G ZXL+4M>E#443D+4)L,@)Y,#/>$KL.+4K./@KL.,GU%52<%$6N=2,R5,"#$W)7"#$7<#,=#-.+I9<%JE= :#+>?6 I9<W)7:G43D+CE)+5C<
N%$A"$4,M;U7<A@$DCB#=AB61#4#$,GU%%&'()*'+#,W$'+ /@KL./%Q,U%*#4E)*3%$61+>R-.+14#>4/01)2"$$42342, 5,@)Y,#
$9%A(("#$79ABI9<%JE=5,$67)(%84094' /@KL.1$<#+>E#4/-F4A-F+5C<")($<#,=#>3?0#@:)LE%$6/:T
! ! ! ! ! ! ! ! 0H.T'$'$)*,R *),%_2#*'
! ! ! ! ! ! ! ! 1 @PTW'"#=, @.T. 2553
!"#"

0H. T'$'$)*,R *),%_2#*'
0.(., Centro Escolar University, %$6/:T`_B'%%_,1R
(a.4. (M.B.A) 4C#E':=#B)=T$M%:34
14#>4/01)2"$$42342, (%$6/:TU:=)
bJ#="#$W)7"#$-<.49B
,#= "'**'E+TR T302)=T'$'"3B
E:.(. 4C#E':=#B)=4C'7B
E:.4., Taxas A&M University, 1C$)8./4$'"#
($'O): Clearsky Solutions
:ML%$X"O#"#$@)Y,#$6((1#$1,/:T
0". "PO?R /IK.">G
0.(. 4C#E':=#B)=4C#1#$>#4
bJ#=@)Y,#$6((1#$1,/:T
0H. "'*'=#@$ $)*,#E$"'*'
0.(. 4C#E':=#B)=T$M,>$',:$RE'N$Y
bJ#="#$W)7"#$-<.49B
0". a,E)Y,R TT'/W$'H2)=
0.(. 4C#E':=#B)=C)E/VM=E/VB'4@$6/"M=$*'
bJ#="#$W)7"#$-<.49B
0H. ,'0#E7M *);+/1<+
0.(. 4C#E':=#B)=4C#1#$>#4
bJ#="#$W)7"#$-<.49B
!$%&'()*+,"

!"#$
>G,G ................................................................................................................................................................................ "
>?6I9<W)7:G ...................................................................................................................................................................... -
1#$()H ............................................................................................................................................................................. >
1#$()H0#@ ....................................................................................................................................................................... +
"#$/*$M=4/>$KL.+>.4@'E/*.$R1GC$)(52<N%$A"$4 Pharmacy MTM ..................................................................................... W
(::ML 1 A,6,G"#$52<N%$A"$4/(K;.+*<, .............................................................................................................................. 1
! "#$/-<#52<+#,N%$A"$4 Pharmacy MTM ................................................................................................................ 2
! "#$.."W#"N%$A"$4 Pharmacy MTM .................................................................................................................. 3
(::ML 2 "#$(),:X"-<.49BI9<%JE= ........................................................................................................................................... 4
! "#$/@'L4$6/(M=,I9<%JE= ............................................................................................................................................ 5
! "#$A"<U-$6/(M=,I9<%JE= ........................................................................................................................................... 6
! "#$><,C#-<.49BI9<%JE= ............................................................................................................................................. 7
! "#$><,C#1#,@=#(#B ......................................................................................................................................... 7
(::ML 3 "#$(),:X"-<.49B"#$79ABI9<%JE= ............................................................................................................................. 12
! "#$(),:X"-<.49B$#="#$=#:MLU7<$)(W#"A@:=R ......................................................................................................... 13
! "#$(),:X"%[HC#W#""#$52<=# .............................................................................................................................. 17
! "#$(),:X"-<.49B"#$*$EW$D#+"#= ......................................................................................................................... 21
! "#$(),:X"-<.49B/"ML=E")("#$5C<>G%$X"O# ............................................................................................................. 24
(::ML 4 $#=+#,1$3%"#$*'7*#4I9<%JE= .............................................................................................................................. 27
! -);,*.,"#$@'4@R$#=+#,1$3%"#$*'7*#4 ............................................................................................................... 28
(::ML 5 -<.49B$#="#$=#AB6E'aM"#$52<=# .......................................................................................................................... 30
! "#$/@'L4-<.49B$#="#$=# ....................................................................................................................................... 31
! "#$/@'L4AB6A"<U-E'aM"#$($'C#$=# ......................................................................................................................... 32
-./0*1

!"#$
$9%:ML 1 Pharmacy MTM icon ............................................................................................................................................ 2
$9%:ML 2 C,<#W.B+2KL./-<#52<+#, (log in) ............................................................................................................................... 2
$9%:ML 3 A17+%3J4 Close -.+C,<#*D#+CB)"-.+N%$A"$4 Pharmacy MTM ........................................................................... 3
$9%:ML 4 A17+0#@/4,9 /@KL..."W#"N%$A"$4 Pharmacy MTM ........................................................................................... 3
$9%:ML 5 A17+C,<#W.1GC$)((),:X"-<.49BI9<%JE= ................................................................................................................... 5
$9%:ML 6 A17+"#$C#$C)1I9<%JE=5C<.)*N,4)*'N7=$C)1:MLU7<W6U4DZ;G ........................................................................................... 6
$9%:XL 7 A17+*)E.=D#+"#$/BK."C)E-<.:ML*<.+"#$><,C# .......................................................................................................... 7
$9%:ML 8 A17+*)E.=D#+"#$><,C#W#"*)E.)"O$ ...................................................................................................................... 7
$9%:ML 9 A17+C,<#W.1GC$)("#$><,C#T9,=R($'"#$13-0#@ 1#,@=#(#B ............................................................................ 8
$9%:ML 10 A17+$C)1-.+1#,@=#(#B:ML><,C# ..................................................................................................................... 8
$9%:ML 11 A17+C,<#W.1GC$)("$."-<.49B%$6E)*':)LEU% ......................................................................................................... 8
$9%:ML 12 A17+C,<#W.1GC$)("#$"$."-<.49B%$6E)*'@P*'"$$413-0#@ ................................................................................ 9
$9%:ML 13 A17+C,<#W.1GC$)("#$"$."-<.49B%$6E)*'"#$/WF(%JE= ......................................................................................... 9
$9%:ML 14 A17+C,<#W.1GC$)("$."-<.49B1#,@=#(#B:MLI9<%JE=$)(($'"#$13-0#@ .............................................................. 10
$9%:ML 15 A17+C,<#W.1GC$)("$."-<.49B%$6E)*'I9<%JE=/@'L4/*'4 .......................................................................................... 11
$9%:ML 16 A17+C,<#W.1GC$)((),:X"-<.49B/"ML=E")($#="#$=#-.+I9<%JE= ............................................................................. 13
$9%:ML 17 A17+"#$/-<#(),:X"-<.49B1DE,-.+$#="#$=#:MLU7<$)(W#"A@:=R ............................................................................ 13
$9%:ML 18 A17+-<.>E#4/*K., /4KL.U4D@(-<.49BI9<%JE= .......................................................................................................... 14
$9%:ML 19 A17+-<.49B/(K;.+*<,-.+I9<%JE= AB6>$);+:ML*'7*#4 .................................................................................................. 14
$9%:ML 20 A17+C,<#*D#+1GC$)(><,C#2KL.=# ........................................................................................................................ 14
$9%:ML 21 A17+"#$>B'":ML%3J4 “Review Medication” /@KL.A17+$#="#$=#:MLI9<%JE=52<5,8#,-<.49B ......................................... 15
$9%:ML 22 A17+%3J4 “(),:X"” 1GC$)((),:X"-<.49B$#="#$=#AB6"#$*'7*#4 ......................................................................... 15
$9%:ML 23 A17+C,<#*D#+1GC$)("#$/BK."$C)1N>$+"#$:ML*<.+"#$ ......................................................................................... 15
$9%:ML 24 A17+0#@B9"T$1GC$)(/BKL.,79-<.49B-.+"#$*'7*#4A*DB6>$);+ .............................................................................. 16
$9%:ML 25 A17+C,<#W."#$"$."-<.49B$#="#$=#:MLI9<%JE=Z';.52</.+ ...................................................................................... 16
$9%:ML 26 A17+C,<#W.1GC$)((),:X"%[HC#W#""#$52<=#-.+I9<%JE= .................................................................................... 17
-./0*12.3

!"#$
$9%:ML 27 A17+"#$(),:X"-<.49B5,"$?M:MLU4D4M%[HC#W#""#$52<=# ....................................................................................... 17
$9%:ML 28 A17+0#@"#$7X+-<.49B$#="#$=#W#"C,<#W. “$#="#$=#:MLU7<$)(W#"A@:=R” ........................................................ 18
$9%:ML 29 A17+C,<#W.-<.49B%[HC#W#""#$52<=#:ML/>=9"(),:X"UE< ..................................................................................... 18
$9%:ML 30 A17+C,<#W."#$/@'L4$#="#$=#:ML/"'7 DRPs ....................................................................................................... 18
$9%:ML 31 A17+0#@"#$A:$"$#="#$=#:ML*<.+"#$/@'L4U7< .................................................................................................. 19
$9%:ML 32 A17+"#$B($#="#$=#:MLU4D*<.+"#$ .................................................................................................................... 19
$9%:ML 33 A17+C,<#W.AB6-);,*.,"#$(),:X"E'aM"#$A"<U-%[HC# (Action) 5,$#="#$=#:ML/"'7 DRPs ................................... 20
$9%:ML 34 A17+C,<#W.AB6-);,*.,"#$B<#+-<.49B$#="#$=#:ML/"'7 DRPs ............................................................................. 20
$9%:ML 35 A17+C,<#W.AB6-);W*.,"#$B<#+-<.49BE'aM"#$A"<U-%[HC# (Action) ...................................................................... 21
$9%:ML 36 A17+C,<#W.1GC$)((),:X"IB"#$:71.(>E#4$9<1X":ML/:<# (Foot screening) AB6-);,*.,"#$(),:X" ...................... 22
$9%:ML 37 A17+C,<#W.1GC$)((),:X"IB"#$*$EW:#+C<.+%&'()*'"#$ (Laboratory Tests) ................................................... 23
$9%:ML 38 A17+C,<#W.1GC$)("#$(),:X"-<.49B/"ML=E")("#$5C<>G%$X"O#A"DI9<%JE= (Counseling) ......................................... 24
$9%:ML 39 A17+C,<#W./"ML=E")(A( Chief Complaint AB6 Medication Counseling .......................................................... 24
$9%:ML 40 A17+C,<#W./"ML=E")( Clinical Counseling .......................................................................................................... 25
$9%:ML 41 A17+C,<#W./"ML=E")( Lifestyle Counseling ........................................................................................................ 25
$9%:ML 42 A17+C,<#W./"ML=E")( Plan and Monitoring ........................................................................................................ 26
$9%:ML 43 A17+C,<#W.1GC$)($#=+#,1$3%IB"#$*'7*#4I9<%JE= .......................................................................................... 28
$9%:ML 44 A17+C,<#W.1GC$)("#$><,C#-<.49BI9<%JE=:ML*<.+"#$ ........................................................................................... 28
$9%:ML 45 A17+C,<#W.-<.49B/(K;.+*<,-.+I9<%JE=:ML*<.+"#$ ................................................................................................... 28
$9%:ML 46 A17+C,<#W."#$"$."(),:X""#$79AB*D./,KL.+ ..................................................................................................... 29
$9%:ML 47 A17+C,<#W.$#=+#,1$3%IB"#$*'7*#479ABI9<%JE=-.+N%$A"$4 .......................................................................... 29
$9%:ML 48 A17+C,<#W."#$1)L+@'4@R1$3%IB"#$*'7*#4I9<%JE=.."4#/%Q,$#=+#, .................................................................. 29
$9%:ML 49 A17+C,<#W.1GC$)("'W"$$4-<.49B$#="#$=#AB6E'aM"#$52<=# .............................................................................. 31
$9%:ML 50 A17+C,<#W."#$/@'L4-<.49B$#="#$=#AB6E'aM"#$/BK.""B3D4=# .............................................................................. 31
$9%:ML 51 A17+C,<#W.$#="#$=#:ML9"(),:X"UE<5,8#,-<.49B-.+=#"B3D4 Dyslipidemia agents ............................................ 32
$9%:ML 52 A17+C,<#W."#$/@'L4-<.49B$#="#$=#AB6E'aM"#$/BK.""B3D4=# .............................................................................. 32

!"#$%#&'($)#*+,-),(./0$%,#1234#56!"#789:;#<!#( Pharmacy MTM
!"#$%&'()#*+,-.%/0+'(12*3)*$
1. Hardware
• CPU 800 MHz Pentium III
• 128 MB RAM
• !"#$%&'()*+ Hard disk ,-./*0 100 MB
2. Sofware
• -.11,2314536*- Windows XP
!456,)7589:/3.8.0
1. Hardware
• CPU 1 GHz Pentiium IV (or higher)
• 256 MB RAM
• !"#$%&'()*+ Hard disk ,-./*0 200 7MB
•
2. Software
• -.11,2314536*- Windows XP

! ! ! %&'()*+,-./0:
c /@KL.5C<I9<52<$9<E'aM"#$/-<#52<N%$A"$4 Pharmacy MTM
c /@KL.5C<I9<52<$9<W)"1)HB)"O?RAB6"'W"$$45,N%$A"$4 Pharmacy MTM
c /@KL.5C<I9<52<$9<E'aM"#$.."W#"N%$A"$4 Pharmacy MTM
4#%#"5./67(89/45/:;0<=>?@(#

!"#$=9"789-">:;#<!#( Pharmacy MTM
! "#$%$&'()*+,#-./$0"$( Pharmacy MTM )1+23+)*+ Double click 45' Pharmacy MTM icon 67,$3/45' 1
$3/45' 1 Pharmacy MTM icon
! %(8'9 Double click 45' Pharmacy MTM icon 0:+; ./$0"$(<=0>6,1-+#<9)1+:,*8'9%?+#)*+,#- 67,$3/45' 2
$3/45' 2 1-+#<9:,*8'9%?+#)*+,#- (log in)
! 23+%?+#)*+@+9,"$9"?+9(3: “*8'923+)*+,#-” (User Name) 0:= “$17>2A#-” (Password) @#(:B67C 0:+;D:&"45' “:,*8'9%?+#)*+
,#-” %(8'923+)*+4B"#$:,*8'9%?+#)*+%>$E<0:+; <=%?+#>3A./$0"$( Pharmacy MTM FG',<=/$#"H$#I"#$"&<"$$(9I3A6+#-C-?;#
?9,<9J#K./$0"$( .6I0>6,%/L->7M:7"NOP@A#,Q
! >7M:7"NOP@A#,Q )-./$0"$( 0>6,RG, $#I"#$"&<"$$(@A#,Q (567,-5S
-&12&3450 3673++8
"'W"$$4"#$(),:X"-<.49BI9<%JE=
"'W"$$4"#$(),:X""#$*'7*#4I9<%JE=
"'W"$$4"#$*$EW>)7"$.+I9<%JE=
"'W"$$4"#$$#=+#,1$3%IB"#$*'7*#4I9<%JE=
"'W"$$4"#$5C<>E#4$9<I9<%JE=
"'W"$$4"#$1D+*D.I9<%JE=
2
!""#$ 1 !"#"$%&'()*+,'!%'-./01234*"

-&12&3450 3673++8
"'W"$$4"#$%$6/4',IB"#$*'7*#4I9<%JE=
-<.49B1#,($'"#$13-0#@
-<.49BN$>AB6>E#4$9<
-<.49B$#="#$=#AB6E'aM"#$52<=#
"#$*);+>D#N%$A"$4
! 0@A%-8'9,<#"./$0"$(I7,9I3A)-*A;,?9,"#$K7T-# 67,-7S-<=(5%K5I,C#,"&<"$$(%4A#-7S-45'>#(#$R)*+,#-U6+ U6+0"A
"&<"$$("#$C7-4G"?+9(3:23+/V;I "&<"$$("#$C7-4G""#$@&6@#(23+/V;I "&<"$$("#$$#I,#->$W/2:"#$@&6@#(23+/V;I 0:=?+9(3:
$#I"#$I#0:=;&X5"#$)*+I#
!"#,,!?"!:;#<!#( Pharmacy MTM
!
! 23+)*+>#(#$R99"<#"./$0"$(U6+ 2 ;&X5 67,-5S
! ;&X545' 1:!D:&"45'/WV( Close ?9,1-+#@A#,1:7"?9,./$0"$( 67,$3/45' 3
! ;&X545' 2:!D:&"45'%(-3 Pharmacy MTM 0:+;%:89" “99"<#" Pharmacy MTM” 67,$3/45' 4
$3/45' 3 0>6,/WV( Close ?9,1-+#@A#,1:7"?9,./$0"$( Pharmacy MTM $3/45' 4 0>6,J#K%(-3 %K8'999"<#"./$0"$( Pharmacy MTM
3
!""#$ 1 !"#"$%&'()*+,'!%'-./01234*"

! ! ! %&'()*+,-./0:
c /@KL.5C<I9<52<1#4#$/@'L4AB6A"<U-$6/(M=,-<.49B/(K;.+*<,-.+I9<%JE=U7<
c /@KL.5C<I9<52<1#4#$><,C#-<.49BI9<%JE=U7<
c /@KL.5C<I9<52<1#4#$><,C#1#,@=#(#BU7<
! ! ! +$92,:;<9=:
! ! ! ! "#$(),:X"A(D+.."/%Q, 5 1DE, U7<A"D
c %$6E)*':)LEU%
c %$6E)*'@P*'"$$413-0#@
c %$6E)*'"#$/WF(%JE=
c 1#,:ML$)(($'"#$13-0#@
c %$6E)*'I9<%JE= (/@'L4/*'4)
5./0*#,A5B(>:'C&'(9DEF

=5@>%,>!"#65>AB!=9,(CDEC9;F0':
!"#$;GH4>9"?,!/?!##(!"#65>AB!=9,(CDEC9;F0'
I
I 23+)*+>#(#$R%?+#>3A"#$C7-4G"?+9(3:23+/V;I .6ID:&"45'>7M:7"NOP “!/?!##(!"#65>AB!=9,(CDEC9;F0'” <#"$#I"#$
"&<"$$(1:7" <#"-7S-./$0"$(<=0>6,1-+#<9>B1$7CC7-4G"?+9(3:23+/V;I 67,$3/45' 5
$3/45' 5 0>6,1-+#<9>B1$7CC7-4G"?+9(3:23+/V;I
! )->A;-?9,"#$C7-4G"?+9(3:23+/V;I-7S- "A9-C7-4G"?+9(3:>A;-98'-Q 23+)*+@+9,4B"#$ “%K&'($=%C5I-23+/V;I” .6I(5?7S-@9-
67,-5S
!"#$./+(#J$6&'>EC9;F0'
"$O545'U(A(5/$=;7@&?+9(3:23+/V;I)-Y#-?+9(3: 23+)*+>#(#$R%K&'($=%C5I-23+/V;I.6ID:&"45'/WV( “$./+(#J$6&'>”
?7S-@9-"#$%K&'($=%C5I-23+/V;I
1. D:&"45'/WV( “$./+(#J$6&'>” ./$0"$(<=%:89"$17>23+/V;I45'U(AFSB.6I97@.-(7@& 67,$3/45' 6
2. 23+)*+@+9,"$9"?+9(3:?9,23+/V;I67,@A9U/-5S )1+D$C<G,<=>#(#$RC7-4G"?+9(3:U6+
! DB-B1-+#
! *8'9--#(>"W:
! %KZ
! 1(3A%:896
! %:?/$=<B@7;/$=*#?-
! ;7-%689-/[%"&6 .6I23+)*+U(A@+9,"$9"9#IW %K$#=./$0"$(<=DB-;O)1+97@.-(7@&
! C+#-%:?45' 0:=/1$89 F9I
! *8'91(3AC+#-1$89*8'9*W(*-
! R--
! 0?;,1$89@BC:
! %?@1$899B%J9
! <7,1;76
! $17>U/$NO5IP
! .4$Z7K4P
5
!""#$ 2 %&'/5"67%8*2-9:;9*,<=>

! >&4X&"#$$7"N#KI#C#:
! Z3-IPC$&"#$>W?J#K .6I)1+"$9"%/L-$17>FG',>#(#$R)*+]^,"P*7'-D+-1#U6+ <=U6+":A#;@A9U/
! *8'9 – -#(>"W: ?9,23+@&6@A9)-"$O5_W"%_&-
! .4$Z7K4P?9,23+@&6@A9)-"$O5_W"%_&-
! D;#(%"5'I;?+9,"7C23+/V;I?9,23+@&6@A9)-"$O5_W"%_&-
3. %(8'9"$9"?+9(3:@#(?+9 2 D$C0:+;)1+D:&"45'/WV( “65>AB!” .6I23+)*+@+9,4B"#$"$9"?+9(3:)1+D$C)-./$0"$( <G,<=
>#(#$RC7-4G"U6+ 1#"?+9(3:*A9,)6U(A>#(#$R%@&(U6+ >#(#$R)>A%D$8'9,1(#I “ – “ 04-U6+
4. "#$C7-4G"?+9(3:23+/V;I?9,"#$%K&'($=%C5I-D$7S,0$" 1#"23+)*+U(A>#(#$R"$9"?+9(3:)->A;-?9,/$=;7@&47';U/ /$=;7@&
K`@&"$$(>W?J#K /$=;7@&"#$%<EC/V;I >R#-45'$7CC$&"#$>W?J#K 0:=/$=;7@&23+/V;I (%K&'(%@&() U6+D$C 23+)*+>#(#$R
":7C(#"$9"?+9(3:%K&'(%@&(U6+ (63$#I:=%95I6)- “"#$0"+U?$=%C5I-”)
5. %(8'94B"#$C7-4G"?+9(3:>B%$E< ./$0"$(<=:+#,?+9(3:47S,1(699" %K8'9%@$5I()1+23+)*+>#(#$R0"+U? 1$89 %K&'($=%C5I-
23+/V;I$#I)1(AU6+
1(#I%1@W: ! )-?O=9I3A.1(6%K&'($=%C5I- 23+)*+U(A>#(#$RD:&"45'/WV(%K&'($=%C5I- 1$89 /$7C/$W,?+9(3:U6+<-";A#<=4B"#$C7-4G"
?+9(3: 1$89I"%:&""#$%K&'($=%C5I--7S-"A9-
$3/45' 6 0>6,"#$1#$17>23+/V;I)1+97@.-(7@&.6I$17>45'U6+<=U(AFSB
!"#<!9K=#J$6&'>EC9;F0'
"$O545')-Y#-?+9(3:(5?+9(3:23+/V;I9I3A0:+; 1#"23+)*+@+9,"#$0"+U??+9(3:C#,>A;- 1$89@+9,"#$%K&'(?+9(3:)->A;-?9,
/$=;7@&47';U/ /$=;7@&K`@&"$$(>W?J#K /$=;7@&"#$%<EC/V;I >R#-45'$7CC$&"#$>W?J#K 0:=/$=;7@&23+/V;I (%K&'(%@&() >#(#$R
4BU6+ 0@AU(A>#(#$R0"+U?$17>23+/V;IU6+
! ?7S-@9-"#$%K&'($=%C5I-23+/V;I
1. 23+)*+@+9,4B"#$D+-1#$=%C5I-23+/V;I45'@+9,"#$ .6I)*+]^,"P*7'-"#$D+-1# (63$#I:=%95I6)- “"#$D+-1#?+9(3:23+/V;I”)
2. D:&"45'/WV( “;#56;#L-=9,(CD”
3. 4B"#$0"+U??+9(3: 1$89 %K&'(%@&(?+9(3:45'@+9,"#$
4. D:&"45'/WV( “65>AB!”
5. %(8'9C7-4G"?+9(3:>B%$E< ./$0"$(<=:+#,?+9(3:47S,1(699" %K8'9%@$5I()1+23+)*+>#(#$R0"+U? 1$89%K&'($=%C5I-23+/V;I
$#I)1(AU6+
!"#'!$D/!!"#$./+( 4#*, !"#<!9K=#J$6&'>
! ?O=45'6B%-&-"#$%K&'( 1$89 0"+U?$=%C5I- 23+)*+>#(#$RI"%:&""#$6B%-&-"#$67,":A#;U6+4W"%(8'9 .6ID:&"45'/WV( “'!$D/!”
./$0"$(<=:+#,?+9(3:47S,1(699" %K8'9%@$5I()1+23+)*+>#(#$R0"+U? 1$89%K&'($=%C5I-23+/V;I$#I98'-@A9U/
6
!""#$ 2 %&'/5"67%8*2-9:;9*,<=>

!"#)9>4"=9,(CDEC9;F0'
I 23+)*+>#(#$RD+-1#?+9(3:23+/V;IU6+ .6ID:&"45'/WV( “)9>4"” 1$89 %:8'9-%D9$P%F9$P(#45' *A9, “)3>34>9"” 0:+;"6 Ctrl +
F <=/$#"H1-+#@A#, 0>6,67,$3/45' 7 – 8
! "#$D+-1#?+9(3:23+/V;I 23+)*+>#(#$RD+-1#U6+<#"
1. *8'9 – -#(>"W:?9,23+/V;I
2. $17>23+/V;I
3. %:?/$=<B@7;/$=*#*-?9,23+/V;I
! ?7S-@9-"#$D+-1#?+9(3:23+/V;I
1. D:&"45'/WV( “)9>4"” 1$89 "6 Ctrl + F %(8'9%D9$P%F9$P9I3A45'*A9, “)3>34>9"”
2. %:89";A#@+9,"#$D+-<#"17;?+9)6
3. K&(KPDB45'@+9,"#$D+-1#)-*A9, “)3)9>”
4. ./$0"$(<=/$#"H$=%C5I-23+/V;I45'(5>A;-?9,@7;97"N$45'%?+#U6+"7CDBD+-
5. "6 Enter %D9$P%F9$P<=%:8'9-(#I7,@#$#,45'0>6,$=%C5I-45'KC
6. %:89"$=%C5I-23+/V;I45'@+9,"#$ %:8'9-C$$476.6I)*+/WV(:3"Z$?GS- – :, 1$89 )*+%(#>PD:&"
7. "6 Enter %(5'9@+9,"#$%:89"$=%C5I- ./$0"$(<=0>6,?+9(3:?9,23+/V;I45'%:89"<#""#$D+-1#
$3/4G' 7 0>6,@7;9IA#,"#$%:89"17;?+945'@+9,"#$D+-1#
$3/45' 8 0>6,@7;9IA#,"#$D+-1#<#"@7;97"N$
!"#)9>4"2M">.'"6"D
"#$"$9"?+9(3:)-*A9,Z3-IPC$&"#$>W?J#K 23+)*+@+9,"$9"?+9(3:%/L-@7;%:?$17>?9,>R#-KI#C#: 1#"23+)*+<B$17>?9,
>R#-KI#C#:U(AU6+ >#(#$R)*+]^,"P*7'-D+-1#>R#-KI#C#: %K8'91#$17>?9,>R#-KI#C#:45'@+9,"#$U6+
! ?7S-@9-"#$D+-1#>R#-KI#C#:
1. %:8'9-%D9$P%F9$P(#45'*A9, “NC>'16#/!"#2L=O".” 1$89 *A9, “2M">.'"6"D” )-"$O545'@+9,"#$%K&'(?+9(3: )->A;-
>R#-45'$7CC$&"#$>W?J#K
2. "6 Ctrl + F <=/$#"H1-+#@A#,>B1$7CD+-1#>R#-KI#C#: 67,$3/45' 9
3. K&(KP*8'9DBD+-)-*A9, “)9>4"NC>'16#/!"#2L=O". 2M">.'"6"D”
4. ./$0"$(<=/$#"H$=%C5I->R#-KI#C#:45'(5>A;-?9,@7;97"N$45'%?+#U6+"7CDBD+-
5. "6 Enter %D9$P%F9$P<=%:8'9-(#I7,@#$#,45'0>6,$=%C5I-45'KC
6. %:89"$=%C5I->R#-KI#C#:45'@+9,"#$ %:8'9-C$$476.6I)*+/WV(:3"Z$?GS- – :, 1$89 )*+%(#>PD:&"
7. "6 Enter %(5'9@+9,"#$%:89"$=%C5I-
8. <=/$#"H$17>?9,>R#-KI#C#:45'D+-1# 67,$3/45' 10
7
!""#$ 2 %&'/5"67%8*2-9:;9*,<=>

!
$3/45' 9 0>6,1-+#<9>B1$7C"#$D+-1#Z3-IPC$&"#$>W?J#K >R#-KI#C#:! ! $3/45' 10 0>6,$17>?9,>R#-KI#C#:45'D+-1#
!"#!#,!;#J05%/A5+0K;
05%ML;#J2-)1: ! %K8'9C7-4G"?+9(3:%"5'I;"7CD;#(>#(#$R)-"#$9A#-1-7,>89 "#$ZG"N# 9#*5K >R#-="#$>($> %Z$NY#-=?9,
23+/V;I0:=D$9CD$7;
$3/45' 11 0>6,1-+#<9>B1$7C"$9"?+9(3:/$=;7@&47';U/
! ?7S-@9-"#$"$9"/$=;7@&47';U/
1. 1:7,<#")*+]^,"P*7'-%K&'($=%C5I-23+/V;I 1$89 0"+U?$=%C5I-23+/V;I
2. %:89"0RC “;#J05%/A5+0K;” 67,$3/45' 11
3. "#$"$9"?+9(3:45'%/L- Drop–down list 23+)*+>#(#$R%:89"%@&(?+9(3:45'(5)-$#I"#$ 1$89>#(#$RK&(KP%K&'(%@&(U6+
4. 23+)*+>#(#$R0-C02-45'45'9I3A?9,23+/V;I .6I Double click C$&%;O45';A#,)@+?+9D;#( “<E>A&+A&+,'CPEC9;F0'” 0:+;%:89"
U]:P$3/J#K02-45'45'9I3A23+/V;I45'@+9,"#$ FG',U]:P$3/J#K45'>-7C>-W-@+9,(5-#(>"W:%/L- JPG %4A#-7S-)
5. %(8'9"$9"?+9(3:D$CR+;-0:+; )1+D:&"45'/WV( “65>AB!” %K8'9C7-4G"?+9(3::,)-Y#-?+9(3: 1$8923+)*+>#(#$R/$7C/$W,
?+9(3:)->A;-98'-Q %*A- /$=;7@&K`@&"$$(>W?J#K /$=;7@&"#$%<EC/V;I %/L-@+- 0:+;DA9ID:&"45'/WV( “65>AB!” D$7S,
%65I; %K8'9C7-4G"?+9(3:45'/$7C/$W,47S,1(6
!"#!#,!;#J05%/.Q%/!##(2L=O".
05%ML;#J2-)1: !%K8'9C7-4G"?+9(3:%"5'I;"7CK`@&"$$("#$630:>W?J#K?9,23+/V;I %*A- "#$K7"2A9- "#$99""B:7,"#I "#$>3C
CW1$5' "#$68'(09:"9a9:P/*#/"#0] $>*#@&9#1#$45'23+/V;I$7C/$=4#-%/L-/$=<B /$=;7@&"#$0K+ I#/9#1#$
?9,23+/V;I 23+<76I#)1+23+/V;I 0:=23+45'630:%$8'9,9#1#$)1+23+/V;I .6I%_K#=?+9(3:%"5'I;"7C"#$0K+I#/9#1#$ @+9,
C7-4G"*8'9I#45'0K+ 0:=9#"#$0K+45'%"&6?GS- 1#"(5"#$0K+I#(#"";A#1-G',*-&6 )1+C7-4G"4W"$#I"#$I#45'23+/V;I
0K+ 23+<76I#)1+23+/V;I 0:=23+630:%$8'9,9#1#$)1+23+/V;I
8
!""#$ 2 %&'/5"67%8*2-9:;9*,<=>

$3/45' 12 0>6,1-+#<9>B1$7C"#$"$9"?+9(3:/$=;7@&K`@&"$$(>W?J#K
!! ?7S-@9-"#$"$9"/$=;7@&K`@&"$$(>W?J#K
1. 1:7,<#")*+]^,"P*7'-%K&'($=%C5I-23+/V;I 1$89 0"+U?$=%C5I-23+/V;I
2. %:89"0RC “;#J05%/.Q%/!##(2L=O".” 67,$3/45' 12
3. "#$"$9"?+9(3:45'%/L- Drop – down list 23+)*+>#(#$R%:89"%@&(?+9(3:45'(5)-$#I"#$ 1$89>#(#$RK&(KP%K&'(%@&(U6+
4. "#$"$9"?+9(3:45'%/L- Checked list 23+)*+>#(#$R%:89"$#I"#$45'@$,"7C?+9(3:45'%"EC 0:=>#(#$RK&(KP%K&'(%@&(U6+
5. "#$"$9"?+9(3:45'%/L-@7;%:89"U6+%K5I,?+9%65I; %*A- "#$K7"2A9- %:89" “%K5I,K9” 1$89 “U(A%K5I,K9” U6+%K5I,
$#I"#$%65I;0:+;$=CW<B-;-*7';.(,"#$-9- 0:=*A;,%;:#45'-9-1:7C %/L-@+-
6. "#$"$9"?+9(3:"#$0K+I# 1$890K+9#1#$ )1+"$9"*8'92:&@J7ObP)-*A9, “'"/,"4"#A&+<.9” 0:="$9"?+9(3:9#"#$
1$899#"#$0>6,)-*A9, “,"!"#” .6I"$9" 1 2:&@J7ObP@A9 1 C$$476
?+9(3:)->A;-98'-Q %*A- /$=;7@&47';U/ /$=;7@&"#$%<EC/V;I %/L-@+- 0:+;DA9ID:&"45'/WV( “65>AB!” D$7S,%65I; %K8'9C7-4G"
?+9(3:45'/$7C/$W,47S,1(6
!"#!#,!;#J05%/!"#$?R6;F0'
05%ML;#J2-)1: !%K8'9C7-4G"?+9(3:%"5'I;"7C9#"#$/.$D?9,23+/V;I47S,1(6 $;(RG,$#I:=%95I6?9,.$D /[45'23+/V;I%$&'((59#"#$/.$D
$;($=I=%;:#45'%/L- (/[) 0:=/$=;7@&"#$%<EC/V;I?9,D$9CD$7;23+/V;I
$3/45' 13 0>6,1-+#<9>B1$7C"#$"$9"?+9(3:/$=;7@&"#$%<EC/V;I
9
!""#$ 2 %&'/5"67%8*2-9:;9*,<=>

! ?7S-@9-"#$"$9"/$=;7@&"#$%<EC/V;I
1. 1:7,<#")*+]^,"P*7'-%K&'($=%C5I-23+/V;I 1$89 0"+U?$=%C5I-23+/V;I
2. %:89"0RC “;#J05%/!"#$?R6;F0'” 67,$3/45' 13
3. "#$"$9"?+9(3:/$=;7@&"#$%<EC/V;I 23+)*+@+9,$=CW.$D/$=<B@7;?9,23+/V;I $#I:=%95I6%K&'(%@&( /[45'%$&'(%/L- $;($=I=
%;:#45'%/L- 0:=/$=;7@&D$9CD$7;45'(5.$D/$=<B@7;-7S-Q 1#"?+9(3:>A;-)6U(A(5 >#(#$R%@&(%D$8'9,1(#I “ – “ 04-
U6+ 0@A)-*A9, “;SA&+$#/+($;T>” 1#"U(A4$#C?+9(3:)1+%@&( “ 0 ” 04-
4. "#$$=CW.$D/$=<B@7; 23+)*+>#(#$R%:89"<#"$#I"#$45'(5)1+ 1$89>#(#$RK&(KP?+9(3:%K&'(%@&(U6+
5. 23+)*+@+9,"$9"?+9(3:4W"*A9,?9,0@A:=0R;)1+D$CR+;- <G,<=>#(#$R%K&'(C$$476%K8'9"$9"?+9(3:.$D/$=<B@7;98'-U6+
?+9(3:)->A;-98'-Q %*A- /$=;7@&47';U/ /$=;7@&K`@&"$$(>W?J#K %/L-@+- 0:+;DA9ID:&"45'/WV( “65>AB!” D$7S,%65I; %K8'9
C7-4G"?+9(3:45'/$7C/$W,47S,1(6
!"#!#,!2M">A&+#566#/!"#2L=O".
05%ML;#J2-)1: !%K8'9C7-4G"?+9(3:%"5'I;"7C>R#-KI#C#:@#(>&4X&"#$$7"N#?9,23+/V;I 0:=>R#-KI#C#:45'23+/V;IU/$7CC$&"#$
<$&,
$3/45' 14 0>6,1-+#<9>B1$7C"$9"?+9(3:>R#-KI#C#:45'23+/V;I$7CC$&"#$>W?J#K
!
! ?7S-@9-"#$"$9">R#-KI#C#:45'$7CC$&"#$>W?J#K
1. "#$"$9">R#-45'$7CC$&"#$>W?J#K 0CA,99"%/L- 2 :7"NO= D89
1.1 >R#-KI#C#:@#(>&4X&"#$$7"N# 1(#IRG, >R#-KI#C#:45'23+/V;IU6+?GS-4=%C5I-)*+>&4X&>R#-KI#C#:)-
.D$,"#$>W?J#KR+;-1-+#
1.2 >R#-KI#C#:45')*+<$&, 1(#IRG, >R#-KI#C#:45'23+/V;I$7CI# 1$89%?+#$7C"#$$7"N#.$D?9,@- 9#<%/L-U6+
47S,>R#-KI#C#:@#(>&4X&"#$$7"N# 1$89>R#-KI#C#:45'23+/V;I%>5IDA#)*+<A#I%9,
2. 1:7,<#")*+]^,"P*7'-%K&'($=%C5I-23+/V;I 1$89 0"+U?$=%C5I-23+/V;I
3. %:89"0RC “2M">A&+#566#/!"#2L=O".” 67,$3/45' 14
4. 23+)*+@+9,"$9"$17>>R#-KI#C#::,)-*A9, “2M">.'"6"D” 0:+;"6 Enter )-?7S-@9--5S23+)*+>#(#$RD+-1#$17>
>R#-KI#C#:U6+.6I"6 Ctrl + F
5. 1#"%/L-$17>45'R3"C7-4G"U;+0:+; ./$0"$(<=0>6,*8'9>R#-KI#C#:)-*A9, “2M">.'"6"D” 0:=$17>>R#-
KI#C#:)-*A9, “#452”
6. ./$0"$(<=%K&'(C$$476)1(A?GS-(#95" 1 C$$476 %K8'9)1+23+)*+>#(#$R"$9"?+9(W:>R#-KI#C#:98'-@A9U/
10
!""#$ 2 %&'/5"67%8*2-9:;9*,<=>

C7-4G"?+9(3:45'/$7C/$W,47S,1(6
!"#!#,!;#J05%/EC9;F0' ($./+($%/()
05%ML;#J2-)1: !%K8'9C7-4G"?+9(3:%"5'I;"7C"#$6B%-&-*5;&@/$=<B;7-?9,23+/V;I0:=D$9CD$7; :7"NO=?9,45'9I3A9#Z7I0:=>J#K
0;6:+9( D;#(%*8'90:=47Z-D@& Z#>-# 0:=/^<<7I98'-Q 45'>A,2:@A9>W?J#K0:="#$)*+I#>R#-KI#C#:@#(
>&4X&"#$$7"N#?9,23+/V;I 0:=>R#-KI#C#:45'23+/V;IU/$7CC$&"#$<$&,
$3/45' 15 0>6,1-+#<9>B1$7C"$9"?+9(3:/$=;7@&23+/V;I%K&'(%@&(
! ?7S-@9-"#$"$9"/$=;7@&23+/V;I (%K&'(%@&()
1. 1:7,<#")*+]^,"P*7'-%K&'($=%C5I-23+/V;I 1$89 0"+U?$=%C5I-23+/V;I
2. %:89"0RC “;#J05%/EC9;F0' ($./+($%/()” 67,$3/45' 15
3. 23+)*+>#(#$RK&(KP?+9(3:U6+%1(89-"7C"#$K&(KP?+9D;#(47';U/
C7-4G"?+9(3:45'/$7C/$W,47S,1(6
11
!""#$ 2 %&'/5"67%8*2-9:;9*,<=>

! ! ! %&'()*+,-./0:!
c 1GC$)(/01)2"$52<(),:X"-<.49B"#$52<=#/143,U@$/IB'*0)?dR13-0#@:MLU7<W#"A@:=R -<.49B
"#$52<=#/143,U@$/IB'*0)?dR13-0#@:MLI9<%JE=ZK;.52</.+ IB"#$*$EW:#C<.+%e'()*'"#$ (IB
*$EW:MLI9<%JE=4M-<.49B.=9D) IB"#$*$EW$D#+"#=-.+/01)2"$2342, ("#$/=ML=4(<#,) IB"#$
*$EW$D#+"#=-.+I9<%JE= (/@'L4/*'4) IB"#$:71.(>E#4$9<1X":XL/:<# (Foot screening) N7=
/V@#6.=D#+='L+ -<.49B/"ML=E")(%[HC#W#""#$52<=#-.+I9<%JE= AB6"#$5C<>G%$X"O#A"DI9<%JE=
(Counseling)
! ! ! +$92,:;<9=:
! ! ! ! "#$(),:X"A(D+.."/%Q, 4 1DE,5CHDf U7<A"D
c Medication ((),:X"-<.49B/"ML=E")($#="#$=# AB6%[HC#W#""#$52<=#-.+I9<%JE=)
c Screening ((),:X"-<.49B/"ML=E")(IB"#$*$EW$D#+"#=-.+I9<%JE=)
c Counseling ((),:X"-<.49B/"ML=E")("#$5C<>G%$X"O#A"DI9<%JE=)
c Pill count ((),:X"WG,E,/4F7=#:MLI9<%JE=A*DB6$#=$)(%$6:#, AB6U7<$)(W#"1#,@=#(#B)
5./0*#,A5B(>:'C5./+'4C&'(9DEF

=5@>%,>!"#65>AB!=9,(CD!"#HC<DEC9;F0':
1.I Medication (65>AB!=9,(CD$!&+'0!56#"'!"#'"=,-EC9;F0')
! !"#$;GH4>9"?,
I 23+)*+>#(#$R%?+#>3A"#$C7-4G"?+9(3:"#$630:23+/V;I .6ID:&"45'>7M:7"NOP ”!/?!##(!"#65>AB!!"#%/H%"(EC9;F0'” <#"
$#I"#$"&<"$$(1:7" 0:=%:89"D:&"45'$#I"#$ “Medication” <#"-7S-./$0"$(<=0>6,1-+#<9>B1$7CC7-4G"?+9(3:%"5'I;"7C
$#I"#$I#?9,23+/V;I 67,$3/45' 16
$3/45' 16 0>6,1-+#<9>B1$7CC7-4G"?+9(3:%"5'I;"7C$#I"#$I#?9,23+/V;I
! !"#65>AB!=9,(CD#"'!"#'"A&+KH9#56?"!<.A'1
I 05%ML;#J2-)1:!%K8'9C7-4G"?+9(3:%"5'I;"7C"#$)*+I#/>(W-UK$/2:&@J7ObP>W?J#K45'U6+23+/V;IU6+$7C<#"0K4IP
$3/45' 17 0>6,"#$%?+#C7-4G"?+9(3:>A;-?9,$#I"#$I#45'U6+$7C<#"0K4IP
! ?7S-@9-"#$C7-4G"?+9(3:$#I"#$I#45'U6+$7C<#"0K4IP
1. %(8'9/$#"H1-+#<9"&<"$$("#$C7-4G"?+9(3:"#$630:23+/V;I )1+%:89"17;?+9 “Medication”
2. %:89"0RC “#"'!"#'"A&+KH9#56?"!<.A'1” 67,$3/45' 17
3. "$9"$17>23+/V;I)-*A9, “Patient Number” >#(#$R)*+]^,"P*7'-D+-1#?+9(3:23+/V;I .6I"6 Ctrl + F ?O=45'
%D9$P%F9$P9I3A)-*A9, “Patient Number”
13
!""#$ 3 %&'/5"67%8*2-9:%&'?9!:;9*,<=>

4. "6 Enter 1#"U(AKC?+9(3:23+/V;I67,":A#; ./$0"$(<=0>6,?+9D;#(%@89- 67,$3/45' 18
$3/45' 18 0>6,?+9D;#(%@89- %(8'9U(AKC?+9(3:23+/V;I
5. %(8'9KC?+9(3:?9,23+/V;I$#I45'@+9,"#$ ./$0"$(<=0>6,?+9(3:%C8S9,@+-?9,23+/V;I 67,$3/45' 19 ?O=%65I;"7-
./$0"$(<=0>6,D$7S,45'?9,"#$@&6@#(D$7S,:A#>W6 %*A- R+#%/L-23+/V;I45'KC)1(A ./$0"$(<=0>6,%/L-"#$@&6@#(D$7S,
45' 1 1#"%/L-23+/V;I45'(5/$=;7@&"#$@&6@#((#0:+; 3 D$7S, ./$0"$(<=0>6,%/L-"#$@&6@#(D$7S,45' 4 %/L-@+-
$3/45' 19 0>6,?+9(3:%C8S9,@+-?9,23+/V;I 0:=D$7S,45'@&6@#(
6. $=CW;7-45'%I5'I(C+#-.6I%:89"<#"*A9, “05>A&+%/H%"(”
7. "$9"?+9(3:$#I"#$I#?9,23+/V;I0@A:=$#I"#$ .6I(5$#I:=%95I667,-5S
7.1 “8*+,'"/)0"(<#-” 23+)*+@+9,%:89"<#"$#I"#$I#45'(5)-Y#-?+9(3: .6I>#(#$RK&(KP@7;97"N$)-:B67C0$"
./$0"$(<=0>6,$#I"#$I#45'@$,"7C@7;97"N$45'K&(KP 1$89>#(#$R)*+]^,"P*7'-"#$D+-1#?+9(3:I# .6I"6
Ctrl + F ?O=45'%D9$P%F9$P 9I3A)-*A9, “8*+,'"/)0"(<#-” <=/$#"H1-+#@A#,>B1$7CD+-1#?+9(3:I# 67,$3/
45' 20
$3/45' 20 0>6,1-+#@A#,>B1$7CD+-1#*8'9I#
7.2 “0/U&789” 23+)*+@+9,$=CW%/L-$17>"#$C$&1#$I# $#I:=%95I6<=":A#;)-C445' 5 1$89>#(#$R$=CW%/L-$3/0CC
98'-U6+ 1#"$#I"#$I#-7S-U(A<B%/L-@+9,DB-;O%(E6I#45'23+/V;I$7C/$=4#-
7.3 $=CW<B-;-%(E6I#45'-7CU6+ <B-;-45')*+U/ .6I./$0"$(>#(#$R"$9"U6+%_K#=?+9(3:45'%/L-@7;%:?
14
!""#$ 3 %&'/5"67%8*2-9:%&'?9!:;9*,<=>

7.4 <B-;-%(E6I#45'$7C%K&'(0:=;7-45'$7CI#%K&'( 23+)*+@+9,$=CW<B-;-%(E6I#45'$7C%K&'()-*A9, “#56$./+(” 0:=$=CW
;7-45'U6+$7CI#%K&'()-*A9, “05>A&+#56'"$./+(” >A;-$#I"#$I#45'U(A(5"#$$7C%K&'(<#"0K4IP )1+$=CW%/L- “ 0 ”
)-*A9, “#56$./+(” FG',<=U(A@+9,$=CW;7-45'$7CI#%K&'( RG,0(+<=(5?+9(3:;7-45')-*A9, “;7-45'$7CI#%K&'(” "E@#(
7.5 “2M">.'"6"D” 23+)*+$=CW*8'9>R#-KI#C#:45'23+/V;IU6+$7C$#I"#$I#-7S-Q .6I"$9"%/L-$17>>R#-
KI#C#: FG',>#(#$R)*+]^,"P*7'-D+-1#?+9(3:>R#-KI#C#:U6+ .6I"6 Ctrl + F ?O=45'%D9$P%F9$P9I3A)-*A9,
“2M">.'"6"D” 1#"U(A4$#C;A#23+/V;I$7CI#$#I"#$-7S-(#<#">R#-KI#C#:)6 >#(#$R$=CW
%D$8'9,1(#I “ – “ U6+
7.6 45'*A9, “2M">.'"6"D” "6 Enter ./$0"$(<=%K&'(C$$476>B1$7C"$9"?+9(3:$#I"#$I#R76U/
1(#I%1@W:! "#$"$9"$#I"#$I#0@A:=$#I"#$ 23+)*+@+9,"$9"?+9(3:)1+D$C4W"*A9, (&_=-7S-./$0"$(<=U(A?GS-C$$476
)1(A)1+
8. )-"$O545'U(A)*A%/L-"#$@&6@#(D$7S,0$" 23+)*+>#(#$RD:&"45'/WV( “Review Medication” >B1$7C6G,?+9(3:$#I"#$I#
?9,23+/V;I45'(5)-Y#-?+9(3:(#0>6,U6+47-45 %K8'9D;#(>=6;"$;6%$E;)-"#$C7-4G" 67,$3/45' 21
$3/45' 21 0>6,"#$D:&"45'/WV( “Review Medication” %K8'90>6,$#I"#$I#45'23+/V;I)*+)-Y#-?+9(3:
9. D:&"45'/WV( “65>AB!” %K8'9C7-4G"?+9(3:$#I"#$I#?9,23+/V;I 67,$3/45' 22
$3/45' 22 0>6,/WV( “C7-4G"” >B1$7CC7-4G"?+9(3:$#I"#$I#0:="#$@&6@#(
10.1#"23+)*+U(AU6+%:89"$17>.D$,"#$ ./$0"$(<=0>6,1-+#@A#,>B1$7C%:89"$17>.D$,"#$ 67,$3/45' 23 23+)*+@+9,%:89"$17>
.D$,"#$45'@+9,"#$0:+;"6 Enter
$3/45' 23 0>6,1-+#@A#,>B1$7C"#$%:89"$17>.D$,"#$45'@+9,"#$
15
!""#$ 3 %&'/5"67%8*2-9:%&'?9!:;9*,<=>

1(#I%1@W: ! "#$%K&'(?+9(3:$#I"#$I#?9,23+/V;I <=%/L-"#$C7-4G"D$7S,45'@&6@#(6+;I _=-7S-"#$C7-4G"?+9(3:"#$630:98'-Q 23+)*+@+9,
%K&'(?+9(3:$#I"#$I#?9,23+/V;I)-0@A:=D$7S,45'@&6@#("A9-
! !"#$D*+,>HC=9,(CD)#5@-A&+%/H%"(
! 23+)*+>#(#$M%:8'9-63?+9(3:"#$@&6@#()-0@A:=D$7S,U6+.6I"#$D:&"/WV(:3"Z$%:8'9-F+#I – ?;# :3"Z$%:8'9-U/4#,F+#I
1(#IRG, D$7S,45'@&6@#("A9-1-+# :3"Z$%:8'9-U/4#,?;# 1(#IRG ,D$7S,45'@&6@#(D$7S,R76U/ .6I<=(5@7;%:?0>6,"B"7CU;+ FG',
1(#I%:? 1 "B:7,0>6,?+9(3:?9,"#$@&6@#(D$7S,45' 1 <#"47S,1(6 3 D$7S, 67,$3/45' 24
$3/45' 24 0>6,J#K:3"Z$>B1$7C%:8'9-63?+9(3:?9,"#$@&6@#(0@A:=D$7S,
! !"#65>AB!#"'!"#'"A&+EC9;F0'V*@,789$,-
I 05%ML;#J2-)1:!! %K8'9C7-4G"?+9(3:%"5'I;"7C"#$)*+I#/>(W-UK$/2:&@J7ObP>W?J#K45'U6+23+/V;IF8S9)*+%9, 45'-9"%1-89
! ! ! ! <#"$#I"#$I#45'23+/V;IU6+$7C<#"0K4IP %K8'9$7"N#.$D?9,@-
$3/45' 25 0>6,1-+#<9"#$"$9"?+9(3:$#I"#$I#45'23+/V;IF&S9)*+%9,
! ?7S-@9-"#$C7-4G"?+9(3:$#I"#$I#45'U6+F8S9)*+%9,
1. "$9"$17>23+/V;I45'@+9,"#$)-*A9, “Patient Number”
2. %:89"0RC “#"'!"#'"A&+V*@,789$,-” <#"0RC$#I"#$ “Medication”
3. D:&"45'/WV(:3"Z$F+#I – ?;# %K8'9%:8'9-U/I7,D$7S,45'@&6@#(45'@+9,"#$
4. "$9"?+9(3:*8'9I#/>(W-UK$/2:&@J7ObP)-*A9, “8*+,'"/)0"(<#-”
5. "$9";&X5)*+?9,23+/V;I)-*A9, “0/U&789” .6I>#(#$R"$9"0CCC$$I#I;&X5)*+U6+
6. "$9">R#-45'45'23+/V;IF8S9I#/>(W-UK$/2:&@J7ObP-7S-)-*A9, “2M">A&+V*@,”
7. $=CW1(#I%1@W)-*A9, “4("'$4%L” (R+#(5)
8. "6 Enter >B1$7C?GS-C$$476)1(A%K8'9"$9"$#I"#$R76U/ .6I4W"*A9,)-0@A:=0R;@+9,(5?+9(3: 1#"*A9,U1-U(A(5
?+9(3:>#(#$R)>A%D$8'9,1(#I “ – ”
9. D:&"45'/WV( “65>AB!” %K8'9C7-4G"?+9(3:$#I"#$I#45'23+/V;IF8S9)*+%9, 67,$3/45' 25
16
!""#$ 3 %&'/5"67%8*2-9:%&'?9!:;9*,<=>
Hot Key (!"#$%&'()*)
! "#$#%&'()*#+,-.&/-&./&+0123%.*)'&-45+/6 7089:*1;<=>/3*;#0?
! ! Ctrl + C!! :9$.*)8*3@(-A%(7B@"#CD@36+01(/B=3%&#)#A(;CD@36E94$#=;FG''H)*#
! ! Ctrl + D!! :9$.*)@).&/-&./&+0127=E%(;-&.
! ! Ctrl + I! ! :9$.*)8*3@(-4I>+01(/B=3%&#)#A(;4I>FG''H)*#
Note

!"#65>AB!;WX4"?"!!"#789'" (DRPs)
05%ML;#J2-)1:! %K8'9C7-4G"?+9(3:%"5'I;"7C/^M1#"#$)*+I#?9,23+/V;I45'KC "#$6B%-&-"#$0"+/^M1# "#$;#,02-%K8'9
@&6@#(2:"#$0"+U?/^M1# 0:=2:?9,"#$0"+/^M1#"#$)*+I#?9,"#$%I5'I(C+#-23+/V;I 0:=/1$89 @&6@#(23+
/V;I)-0@A:=D$7S,
$3/45' 26 0>6,1-+#<9>B1$7CC7-4G"/^M1#<#""#$)*+I#?9,23+/V;I
! ?7S-@9-"#$C7-4G"?+9(3:/^M1#<#""#$)*+I# (DRPs)
1. "$9"$17>23+/V;I45'@+9,"#$)-*A9, “Patient Number”
2. %:89"0RC “;WX4"?"!!"#789'"” <#"0RC$#I"#$ “Medication”
3. D:&"45'/WV(:3"Z$F+#I – ?;# %K8'9%:8'9-U/I7,D$7S,45'@&6@#(45'@+9,"#$
4. "$9"?+9(3:/^M1#<#""#$)*+I# >B1$7C"#$"$9"?+9(3:/^M1#<#""#$)*+I#-7S- >#(#$R0CA,U6+%/L- 3 "$Oc 67,-5S
! ! !#Y&A&+ 1:I 23+/V;IU(A%"&6/^M1#<#""#$)*+I#)-"#$@&6@#(D$7S,-7S-
! ! ! ! 1.1 ! D:&"%D$8'9,1(#I ! )-*A9, “K(P$!/H;WX4"?"!!"#789'"” 67,$3/45' 27 (A)
! ! ! ! 1.2 ! D:&"45'/WV( “65>AB!” %K8'9C7-4G"?+9(3: .6I1-+#<9<=0>6,?+9D;#(0<+,;A#?+9(3:U6+R3"
! ! ! ! ! C7-4G"0:+; 67,$3/45' 27 (B)
$3/45' 27 0>6,"#$C7-4G"?+9(3:)-"$O545'U(A(5/^M1#<#""#$)*+I#
! ! !#Y&A&+ 2:! 23+)*+I7,U(A%DIC7-4G"?+9(3:/^M1#<#""#$)*+I#?9,"#$@&6@#(D$7S,-7S- ./$0"$(<=6G,$#I"#$I#
! ! ! ! <#"1-+#<9 “#"'!"#'"A&+KH9#56?"!<.A'1” 67,$3/45' 28
17
!""#$ 3 %&'/5"67%8*2-9:%&'?9!:;9*,<=>
(A)
(B)

$3/45' 28 0>6,J#K"#$6G,?+9(3:$#I"#$I#<#"1-+#<9 “$#I"#$I#45'U6+$7C<#"0K4IP”
! ! !#Y&A&+ 3:I 23+)*+U6+C7-4G"?+9(3:/^M1#<#""#$)*+I#)-"#$@&6@#(D$7S,-7S-0:+; ./$0"$(<=0>6,?+9(3:/^M1#
! ! ! ! <#""#$)*+I#45'U6+R3"C7-4G"U;+ 23+)*+>#(#$R0"+U?0:=%K&'(%@&($#I"#$I#45'(5 DRPs U6+ 67,$3/45' 30
! ! ! ! ("#$0"+U?0:=%K&'(%@&(63$#I:=%95I6)- “"#$%K&'(%@&($#I"#$I#45'%"&6 DRPs”)
$3/45' 29 0>6,1-+#<9?+9(3:/^M1#<#""#$)*+I#45'%DIR3"C7-4G"U;+
#"'DJ$,&'H!"#65>AB!;WX4"?"!!"#789'" (Drug Related Problems: DRPs)
I !"#$./+(#"'!"#'"A&+$!/H DRPs: )-"$O545'KC/^M1#<#""#$)*+I# (DRPs) %K&'(%@&(
$3/45' 30 0>6,1-+#<9"#$%K&'($#I"#$I#45'%"&6 DRPs
! ?7S-@9-"#$%K&'($#I"#$I#45'%"&6 DRPs
1. D:&"45'/WV( “$./+(” ./$0"$(<=%K&'(C$$476;A#)1+ 1 0R; 67,$3/45' 30
2. %:89"45'*A9, “8*+,'"” "6 Ctrl + F %K8'9D+-1#$#I"#$I#45'@+9,"#$ 67,$3/45' 30
3. %:89"$17>/^M1#<#""#$)*+I#)-*A9, “DRP” 67,$3/45' 30
18
!""#$ 3 %&'/5"67%8*2-9:%&'?9!:;9*,<=>
1
2 3 4 5
6

4. %:89"$17>2:"#$0"+U?/^M1#)-*A9, “Result” 67,$3/45' 30
5. "$9"$#I:=%95I6/^M1#<#""#$)*+I#)-*A9, “4("'$4%L” 67,$3/45' 30
6. %(8'9"$9"?+9(3:D$C4W"$#I"#$0:+; D:&"45'/WV( “C7-4G"” %K8'94B"#$C7-4G"?+9(3:
! !"#<A#!#"'!"#'"A&+$!/H DRPs: )-"$O545'I#1-G',$#I"#$(5/^M1#<#""#$)*+I# (DRPs) (#"";A# 1 /^M1#
$3/45' 31 0>6,J#K"#$04$"$#I"#$I#45'@+9,"#$%K&'(U6+
! ?7S-@9-"#$%K&'($#I"#$I#45'%"&6 DRPs
1. %:89"$#I"#$I#45'@+9,"#$$=CW DRPs %K&'( 67,$3/45' 31
2. D:&"45'/WV( “<A#!” ./$0"$(<=4B"#$%K&'(*A9,$#I"#$I#45'%:89"95" 1 0R; 67,$3/45' 31
3. %:89"$17>/^M1#<#""#$)*+I#)-*A9, “DRP”
4. %:89"$17>2:"#$0"+U?/^M1#)-*A9, “Result”
5. "$9"$#I:=%95I6/^M1#<#""#$)*+I#)-*A9, “4("'$4%L”
6. %(8'9"$9"?+9(3:D$C4W"$#I"#$0:+; D:&"45'/WV( “C7-4G"” %K8'94B"#$C7-4G"?+9(3:
! !"#D6#"'!"#'"A&+K(P%9,-!"#
$3/45' 32 0>6,"#$:C$#I"#$I#45'U(A@+9,"#$
! ?7S-@9-"#$:C$#I"#$I#45'U(A@+9,"#$
1. %:89"$#I"#$I#45'@+9,"#$:C 0:+;D:&"45'/WV( “:C” 67,$3/45' 32
2. 1-+#<9<=/$#"H?+9D;#(0<+, %K8'9I8-I7-"#$:C )1+D:&"45'/WV( “Yes” %K8'9I8-I7- 67,$3/45' 32
19
!""#$ 3 %&'/5"67%8*2-9:%&'?9!:;9*,<=>
2
3
1
1.2
1.1
2

! !"#65>AB!0/U&!"#<!9K=;WX4" (Action) 7>#"'!"#'"A&+$!/H DRPs
$3/45' 33 0>6,1-+#<90:=?7S-@9-"#$C7-4G";&X5"#$0"+U?/^M1# (Action) )-$#I"#$I#45'%"&6 DRPs
! ?7S-@9-"#$C7-4G";&X5"#$0"+U?/^M1# (Action)
1. %:89"$#I"#$I#45'@+9,"#$
2. D:&"%D$8'9,1(#I ! )-*A9, “Check” 1-+#$17> Action 45'@+9,"#$
3. "$9";&X5"#$0"+U?/^M1#)-*A9, “4("'$4%L” 67,$3/45' 33
4. D:&"45'/WV( “C7-4G"” "A9-45'<=%:8'9-U/%:89"$#I"#$I#98'-Q (&_=-7S-./$0"$(<=U(A4B"#$C7-4G"?+9(3:)1+"7C$#I"#$
I#45'U6+"$9"?+9(3:U/
!"#D9"-=9,(CD7>#"'!"#;WX4"?"!!"#789'" (DRPs)
I !"#D9"-=9,(CD#"'!"#'"A&+$!/H DRPs
$3/45' 34 0>6,1-+#<90:=?7S-@9-"#$:+#,?+9(3:$#I"#$I#45'%"&6 DRPs
! ?7S-@9-"#$C7-4G";&X5"#$0"+U?/^M1# (Action)
1. D:&"45'@#$#, DRP
2. D:&"45'/WV( “Clear” <=/$#"H?+9D;#(0<+,%@89- 67,$3/45' 34
3. D:&"45'/WV( “OK”
4. D:&"45'/WV( “65>AB!” %K8'94B"#$C7-4G""#$0"+U??+9(3:
20
!""#$ 3 %&'/5"67%8*2-9:%&'?9!:;9*,<=>
2
1
4 3
1 2
3
4

! !"#D9"-=9,(CD0/U&!"#<!9K=;WX4" DRPs (Actions)
$3/45' 35 0>6,1-+#<90:=?7S<@9-"#$:+#,?+9(3:;&X5"#$0"+U?/^M1# (Action)
! ?7S-@9-"#$C7-4G";&X5"#$0"+U?/^M1# (Action)
1. D:&"45'@#$#, Action
2. D:&"45'/WV( “Clear” <=/$#"H?+9D;#(0<+,%@89- 67,$3/45' 35
3. D:&"45'/WV( “OK”
4. D:&"45'/WV( “65>AB!” %K8'94B"#$C7-4G""#$0"+U??+9(3:
2.! Screening (65>AB!=9,(CD$!&+'0!56ED!"#%#0?#P"-!"'=,-EC9;F0')
I !"#$;GH4>9"?,
I 23+)*+>#(#$R%?+#>3A"#$C7-4G"?+9(3:"#$630:23+/V;I .6ID:&"45'>7M:7"NOP ”!/?!##(!"#65>AB!!"#%/H%"(EC9;F0'” <#"
$#I"#$"&<"$$(1:7" 0:=%:89"D:&"45'$#I"#$ “Screening” <#"-7S-./$0"$(<=0>6,1-+#<9>B1$7CC7-4G"?+9(3:%"5'I;"7C2:
"#$@$;<$A#,"#I?9,23+/V;I
21
!""#$ 3 %&'/5"67%8*2-9:%&'?9!:;9*,<=>
1
2
3
4
! AJK+01-9@*;+9-&.)*#+,-.&/-&./&+01L-M3FGN$&'&--&."<%/&(/B=#*?#'K27=:&7&.I8@M-L5O1(LF@01/#
2F4I).&/-&.(O1#23% E%(;8@M-FHP7 “)*#+,-” -=(#',;'K:&7&.IL@O(-4I).&/-&.(O1# $&-5/&/&7LF@01/#2F
4I).&/-&. 'KF.&-QA%(8>&7LEO(# 3*;.BF
!
!
! $&-E%(;-&./-L@M--&.)*#+,-.&/-&./&+01L-M3FRN$&'&--&."<%/& (DRPs)
Note

! 2.1 !"#65>AB!ED!"#AH2,6)0"(#C92B!A&+$A9" (Foot screening)
I 05%ML;#J2-)1:II %K8'9C7-4G"?+9(3:"#$46>9CD;#($3+>G"45'%4+#*9,23+/V;I >B1$7C"#$/$=%(&-0:=%/$5IC%45ICJ#;=
! ! ! ! $A#,"#I?9,23+/V;I )-"#$99"%I5'I(C+#-23+/V;I0@A:=D$7S, .6I>#(#$R)*+CA,*5S/$=>&4X&2:"#$630:
! ! ! ! 0:=@&6@#(23+/V;I
$3/45' 36 0>6,1-+#<9>B1$7CC7-4G"2:"#$46>9CD;#($3+>G"45'%4+# (Foot screening) 0:=?7S-@9-"#$C7-4G"
! ?7S-@9-"#$C7-4G"2:"#$46>9CD;#($3+>G"45'%4+# (Foot screeing)
1. "$9"$17>23+/V;I45'@+9,"#$:,)-*A9, “Patient Number”
2. %:89"0RC$#I"#$ “Foot screening” <#"0RC$#I"#$ “Screening” 67,$3/45' 36
3. D:&"45'/WV(:3"Z$F+#I – ?;# %K8'9%:8'9-U/I7,D$7S,45'@&6@#(45'@+9,"#$
4. D:&"C$&%;O<W6@A#,Q %K8'9$=CWDA#D;#($3+>G" F8',./$0"$(<=1(W-%/L-;,<$67,-5S
! ! ! ! 0P"- ! "
! ! FG',0@A:=DA#(5D;#(1(#I D89!
! ! ! ! ! 1(#IRG,! <W6C$&%;O-7S- 23+/V;I(5D;#($3+>G"
! ! ! 0P"-! 1(#IRG,! <W6C$&%;O-7S- 23+/V;IU(AU6+$7C"#$@$;<
! ! ! "! 1(#IRG,! <W6C$&%;O-7S- 23+/V;IU(A(5D;#($3+>G" 1$89 $3+>G"2&6<W6
5. 1#"%4+#?9,23+/V;I (5D;#($3+>G"4W"<W6 >#(#$RD:&"45'/WV( “!All”
6. 1#"%4+#?9,23+/V;I U(A(5D;#($3+>G"4W"<W6 >#(#$RD:&"45'/WV( “" All”
7. >#(#$R"$9"?+9(3:%K&'(%@&(U6+ )-*A9, “#"'DJ$,&'H$./+($%/( (M9"(&)” 67,$3/45' 36
8. 1#"@+9,"#$:+#,?+9(3:45'C7-4G")-1-+#<9-5S )1+D:&"45'/WV( “Clear” 67,$3/45' 36
9. D:&"45'/WV( “65>AB!” %K8'94B"#$C7-4G"?+9(3:
22
!""#$ 3 %&'/5"67%8*2-9:%&'?9!:;9*,<=>
2
7
4
9 8
3
SF.4-.7'K89#>J8K4##8>&7L:01/;A(;L+%&4E=@KA%&;"$%(*ES#7*EM
Note

I 2.2 !"#65>AB!ED!"#%#0?A"-49,-;Z/65%/!"# (Laboratory Tests)
! 05%ML;#J2-)1:!! %K8'9C7-4G"?+9(3:2:"#$@$;<4#,1+9,/H&C7@&"#$ (2:@$;<45'23+/V;I(5?+9(3:9I3A) 2:"#$@$;<
! ! ! ! $A#,"#I?9,%J>7*"$*W(*- ("#$%I5'I(C+#-) >B1$7C%/L-?+9(3:0>6,J#;=$A#,"#I?9,23+/V;I
! ! ! ! 0:=%/$5IC%45ICJ#;=$A#,"#I?9,23+/V;I )-"#$99"%I5'I(C+#-23+/V;I0@A:=D$7S,
$3/45' 37 0>6,1-+#<9>B1$7CC7-4G"2:"#$@$;<4#,1+9,/d&C7@&"#$ (Laboratory Tests)
! ?7S-@9-"#$C7-4G"2:"#$@$;<4#,1+9,/d&C7@&"#$ (Laboratory Tests)
2. %:89"0RC$#I"#$ “Laboratory Tests” <#"0RC$#I"#$ “Screening” 67,$3/45' 37
3. %:89"0RC":WA(DA#2:"#$@$;<45'@+9,"#$ .6I./$0"$(<=0CA,%/L- 6 ":WA( 67,-5S
! DM %*A- Fasting Blood Glucose, Hemoglobin A1c %/L-@+-
! Dyslipidemia %*A- Total cholesterol, Triglyceride, LDL-C %/L-@+-
! Liver function %*A- AST, ALT, Total bilirubin %/L-@+-
! Renal function %*A- BUN, SCr, CrCl %/L-@+-
! Vital sign %*A- Blood Pressure, Heart rate, BMI %/L-@+-
! Warfarin
4. D:&"45'/WV(:3"Z$F+#I – ?;# %K8'9%:8'9-U/I7,D$7S,45'@&6@#(45'@+9,"#$
5. "$9"?+9(3:DA#2:@$;<?9,23+/V;I)-*A9, “)P"=,-EC9;F0'” 67,$3/45' 37
6. "$9"?+9(3:;7-45'@$;<?9,DA#2:@$;<-7S-Q )-*A9, “05>A&+%#0?” 67,$3/45' 37
7. 1#"4$#C>R#-KI#C#:45'23+/V;IU6+$7CDA#2:@$;<(# )1+$=CW)-*A9, “8*+,2M">.'"6"D” 67,$3/45' 37 0:=23+)*+@+9,
"$9"%/L-$17>>R#-KI#C#: FG',>#(#$R)*+]^,"P*7'-D+-1#>R#-KI#C#:U6+
8. D:&"45'/WV( “65>AB!” %K8'94B"#$C7-4G"?+9(3:"A9-45'<=%:8'9-:3"Z$ 1$89%:8'9-U/0RCDA#2:@$;<":WA(98'-Q
23
!""#$ 3 %&'/5"67%8*2-9:%&'?9!:;9*,<=>
2
3
4
65 7
8
TB%"<%27='9LFU#E%(;-.(-8=&T@-&.E.>'+&;$%(;FQM)*EM-&.+H-.&/-&. "$%-.(-LV5&K.&/-&.+0170A%(7B@
Note

3.I Counseling (65>AB!=9,(CD$!&+'0!56!"#749)3;#B!["<!PEC9;F0')
I 05%ML;#J2-)1:I
1. %K8'9C7-4G"?+9(3:%"5'I;"7C"&<"$$(,#-C$&C#:4#,%J>7*"$$(?9,%J>7*"$*W(*-
2. %K8'9%/L-0-;4#,)-"#$@&6@#(2:)-"#$0"+U?/^M1# )-"$O545'KC/^M1#?9,23+/V;I45'@+9,6B%-&-"#$0"+U?
I !"#$;GH4>9"?,
! 23+)*+>#(#$R%?+#>3A"#$C7-4G"?+9(3:"#$630:23+/V;I .6ID:&"45'>7M:7"NOP ”"&<"$$("#$C7-4G""#$@&6@#(23+/V;I” <#"
$#I"#$"&<"$$(1:7" 0:=%:89"D:&"45'$#I"#$ “Counseling” <#"-7S-./$0"$(<=0>6,1-+#<9>B1$7CC7-4G"?+9(3:%"5'I;"7C"#$
)1+DB/$G"N#0"A23+/V;I 67,$3/45' 38
$3/45' 38 0>6,1-+#<9>B1$7C"#$C7-4G"?+9(3:%"5'I;"7C"#$)1+DB/$G"N#0"A23+/V;I (Counseling)
! ?7S-@9-"#$C7-4G""#$)1+DB/$G"N#0"A23+/V;I
2. %:89"0RC$#I"#$ “Counseling”
3. D:&"45'/WV(:3"Z$F+#I – ?;# %K8'9%:8'9-U/I7,D$7S,45'@&6@#(45'@+9,"#$
4. %:89"0RC$#I"#$IA9I0:=*A9,>B1$7C"$9"?+9(3:45'@+9,"#$ .6I0CA,U6+67,-5S
4.1 “Chief Complaint” >B1$7CC7-4G"9#"#$45'4B)1+23+/V;I$3+>G"U(A>C#I <#"DBC9"%:A#?9,23+/V;I%9,67,$3/45' 39
4.2 “Medication Counseling” >B1$7CC7-4G""#$)1+DB/$G"N#6+#-I#0"A23+/V;I 0CA,%/L- 3 >A;- D89
4.2.1 *A9, “DRPs” 67,$3/45' 39
4.2.2 *A9, “DRPs***$./+($%/(***” 67,$3/45' 39
4.2.3 *A9, “ED!"#<!9K=;WX4"” 67,$3/45' 39
$3/45' 39 0>6,1-+#<9%"5'I;"7C0RC Chief Complaint 0:= Medication Counseling
24
!""#$ 3 %&'/5"67%8*2-9:%&'?9!:;9*,<=>
4.1
4.2.1 4.2.2 4.2.3

! ! .6I*A9, “DRPs” 0:=*A9, “ED!"#<!9K=;WX4"” ./$0"$(<=6G,?+9(3:<#"$#I"#$I#45'%"&6/^M1#<#""#$)*+
I#(#0>6,.6I97@.-(7@& U(A<B%/L-@+9,"$9"?+9(3:)- 2 *A9,-5S >A;-*A9, “DRPs***$./+($%/(***” 23+)*+>#(#$R"$9"?+9(3:
DRPs %K&'(%@&( 45'-9"%1-89<#""#$C7-4G"/^M1#<#""#$)*+I#0@A:=$#I"#$U6+
$3/45' 40 0>6,1-+#<9%"5'I;"7C Clinical Counseling
4.3 “Clinical Counseling” >B1$7CC7-4G""#$)1+DB/$G"N#%"5'I;"7C.$D45'23+/V;I%/L- 1$892:"#$@$;<$A#,"#I?9,
23+/V;I 0CA,99"%/L- 3 >A;- D89
4.3.1 *A9, “;WX4"?"!:#)A&+EC9;F0'$;T>” >B1$7C"$9"/^M1#45'%/L- Clinical symptoms .6I)1+"$9" 1
/^M1# @A9 1 C$$476 67,$3/45' 40
4.3.2 *A9, “!"#H3$>/>!"#<!9K=;WX4" Clinical” >B1$7C"$9"$#I:=%95I6"#$0"+U?/^M1#%"5'I;"7C
Clinical symptoms ?9,23+/V;I 67,$3/45' 40
4.3.3 *A9, “ED!"#<!9K=;WX4"” >B1$7C"$9"2:?9-"#$0"+U?/^M1# Clinical symptoms ?9,23+/V;I 67,$3/
45' 40
$3/45' 41 0>6,1-+#<9%"5'I;"7C Lifestyle Counseling
4.4 “Lifestyle Counseling” >B1$7CC7-4G""#$)1+DB/$G"N#%"5'I;"7C/^M1#K`@&"$$("#$6B%-&-*5;&@?9,23+/V;I
0CA,99"%/L- 3 >A;- D89
4.4.1 *A9, “;WX4"?"!.Q%/!##(!"#H3$>/>8&0/%” >B1$7C"$9"?+9(3:45'%/L-/^M1#<#"K`@&"$$("#$
6B%-&-*5;&@?9,23+/V;I .6I)1+"$9" 1 /^M1# @A9 1 C$$476 67,$3/45' 41
4.4.2 *A9, “!"#H3$>/>!"#<!9K=;WX4" Lifestyle” >B1$7C"$9"$#I:=%95I6"#$0"+U?/^M1#<#"K`@&"$$(
"#$6B%-&-*5;&@?9,23+/V;I 67,$3/45' 41
4.4.3 *A9, “ED!"#<!9K=;WX4"” >B1$7C"$9"2:?9-"#$0"+U?/^M1#<#"K`@&"$$("#$6B%-&-*5;&@?9,23+
/V;I 67,$3/45' 41
25
!""#$ 3 %&'/5"67%8*2-9:%&'?9!:;9*,<=>
4.3.1 4.3.3
4.4.1 4.4.2 4.4.3
4.3.2

$3/45' 42 0>6,1-+#<9%"5'I;"7C Plan and Monitoring
4.5 “Plan and Monitoring” >B1$7CC7-4G"?+9(3:"#$;#,02-%K8'9"#$@&6@#(/^M1#6+#-@A#,Q ?9,23+/V;I 0CA,
99"%/L- 3 >A;- D89
4.5.1 *A9, “!"#0"-<E>!"#<!9K=;WX4"” >B1$7C"$9"?+9(3:"#$;#,02-%K8'9@&6@#(/^M1#?9,23+/V;I 67,
$3/45' 42
4.5.2 *A9, “!"#0"-<E>!"#749)0"(#C9EC9;F0'” >B1$7C"$9"?+9(3:"#$;#,02-"#$)1+D;#($3+23+/V;I)-"#$
@&6@#(D$7S,@A9U/ 67,$3/45' 42
4.5.3 *A9, “<E>!"#%/H%"(EC9;F0'” >B1$7C"$9"?+9(3:%"5'I;"7C02-"#$@&6@#(45'-9"%1-89<#""#$"$9"
)-*A9, “!"#0"-<E>!"#749)0"(#C9EC9;F0'” 67,$3/45' 42
26
!""#$ 3 %&'/5"67%8*2-9:%&'?9!:;9*,<=>
4.5.1 4.5.2 4.5.3

! ! ! %&'()*+,-./0:!
c /@KL./%Q,1DE,-.+"#$$#=+#,1$3%IB"#$*'7*#4I9<%JE= W#""#$/=ML=4(<#,-.+/01)2"$2342,
5,A*DB6>$);+
c /@KL./%Q,1DE,-.+"#$$#=+#,1$3%IB"#$79ABI9<%E=:);+C47 5C<:M41CE'2#2M@52</%Q,-<.49B5,
"#$79ABI9<%JE=$DE4"),
/.F?.#-/G95./@H+@.:&'(9DEF

>&?"';"3$++$9.$"-+)*@23$+'6='$8@A#*B%9:
3$+:*C=!"#$7;3673++83$++$9.$"-+)*@23$+'6='$8@A#*B%9
! I9<52<1#4#$/-<#19D"'W"$$4$#=+#,1$3%IB"#$*'7*#4I9<%JE= N7=>B'":ML1)HB)"O?R “"'W"$$4"#$$#=+#,1$3%IB"#$
*'7*#4I9<%JE=” W#"$#="#$"'W"$$4CB)" W#",);,N%$A"$4W6A17+C,<#W.1GC$)("'W"$$4 7)+$9%:ML 43
$9%:ML 43 A17+C,<#W.1GC$)($#=+#,1$3%IB"#$*'7*#4I9<%JE=
! /4KL.I9<52<(),:X"-<.49B"#$*'7*#45,"#$/=ML=4(<#,A*DB6>$);+ 1#4#$@'4@R.."4#/%Q,$#=+#, N7=$#=+#,,M;W6/%Q,"#$
1$3%-<.49B/(K;.+*<,-.+I9<%JE= AB6-<.49BIB-.+"#$*'7*#479ABI9<%JE=WG,E, 3 >$);+BD#137 *)E.=D#+/2D, <#I9<%JE=U7<$)("#$/=ML=4
(<#,N7=/01)2"$2342,WG,E, 8 >$);+ N%$A"$4W6@'4@R$#=+#,1$3%-<.49B"#$79AB >$);+:ML 6, 7 AB6 8 /%Q,*<,
! -);,*.,"#$@'4@R$#=+#,1$3%IB"#$*'7*#4I9<%JE=
1. "$."$C)1I9<%JE=:ML*<.+"#$B+5,2D.+ “Patient Number” AB<E"7 Enter 7)+$9%:ML 44
2. I9<52<1#4#$52<`[+"R2)L,><,C#I9<%JE= N7="7Ctrl + F 5,2D.+ “Patient Number” W6%$#"eC,<#*D#+1GC$)(><,C#I9<
%JE= 7)+$9%:ML 44
3. /4KL."7 Enter N%$A"$4W6A17+-<.49B/(K;.+*<,-.+I9<%JE= 7)+$9%:ML 45
!
!
! $9%:ML 44 A17+C,<#W.1GC$)("#$><,C#-<.49BI9<%JE=:ML*<.+"#$! ! $9%:ML 45 A17+C,<#W.-<.49B/(K;.+*<,-.+I9<%JE=:ML*<.+"#$
28
!""#$ 4 '&>3&"@'A,%&'4B?4&-;9*,<=>
1
2

4. "#$@'4@R$#=+#,1$3%IB"#$*'7*#4I9<%JE=,);, /01)2"$2342,I9<52<>E$"$."-<.49B"#$79AB*D./,KL.+1GC$)(I9<%JE=
A*DB6$#= /@KL./%Q,-<.49B5C<")(:M41CE'2#2M@52<79ABI9<%JE=*D.U% N7=5C<>B'":ML$#="#$ “(),:X""#$79AB*D./,KL.+” 7)+
$9%:ML 46
5. 5,$#="#$ “(),:X""#$79AB*D./,KL.+” /01)2"$2342,I9<52<*<.+$6(3
5.1 2D.+ “/01)2"$2342,/=ML=4(<#,” 5C<"$."-<.49B 2KL. – ,#41"3B /01)2"$2342,:ML79ABI9<%JE= 7)+$9%:ML 46
5.2 2D.+ “/B-:ML5(%$6".(E'2#2M@” 5C<"$."-<.49B/B-:ML5(%$6".(E'2#2M@ 7)+$9%:ML 46
5.3 2D.+ “$<#,=#” 5C<"$."-<.49B 2KL.$<#,=#:ML/01)2"$2342,%&'()*'+#,.=9D 7)+$9%:ML 46
6. /4KL."$."-<.49B>$(AB<E5C<>B'":ML%3J4 “Save / Preview report” 7)+$9%:ML 46
7. W#",);,N%$A"$4W6A17+$#=+#,1$3%IB"#$*'7*#479ABI9<%JE= 7)+$9%:ML 47
! $9%:ML 46 A17+C,<#W."#$"$."(),:X""#$79AB*D./,KL.+! $9%:ML 47 A17+C,<#W.$#=+#,1$3%IB"#$*'7*#479ABI9<%JE=-.+N%$A"$4
8. I9<52<1#4#$1)L+@'4@R1$3%IB"#$*'7*#4I9<%JE=.."4#/%Q,$#=+#,:#+/>$KL.+@'4@RU7< N7=>B'":ML$9%/>$KL.+@'4@R W6
%$#"eC,<#*D#+1GC$)(1)L+@'4@R 7)+$9%:ML 48
$9%:ML 48 A17+C,<#W."#$1)L+@'4@R1$3%IB"#$*'7*#4I9<%JE=.."4#/%Q,$#=+#,
29
!""#$ 4 '&>3&"@'A,%&'4B?4&-;9*,<=>
4
5.2
5.1
5.3
6

! ! ! %&'()*+,-./0:
! ! ! ! /@KL.5C<I9<52<1#4#$/@'L4AB6A"<U-$#="#$=#5,8#,-<.49BU7<
! ! ! ! /@KL.5C<I9<52<1#4#$/@'L4AB6A"<U-E'aM"#$52<=#5,8#,-<.49BU7<
! ! ! +$92,:;<9=:!
! ! ! ! -<.49B$#="#$=#AB6E'aM"#$52<=# A(D+.."/%Q, 2 1DE, U7<A"D
c "#$/@'L4-<.49B$#="#$=#
c "#$/@'L4AB6A"<U-E'aM"#$($'C#$=#
B(>:'C/.F5./F.4C%EHIJ5./67(F.

>&?"';"3$+:>#$3673++8>#;8A2+$93$+9$D2,%6E<3$+FG#9$:
3$+:*C=!"#$7;
! I9<52<1#4#$/-<#19D"#$/@'L4-<.49B$#="#$=# N7=>B'":ML1)HB)"O?R “3673++8>#;8A2+$93$+9$D2,%6E<FG#9$” W#"
$#="#$"'W"$$4CB)" W#",);,N%$A"$4W6A17+C,<#W.1GC$)("'W"$$4 7)+$9%:ML 49
$9%:ML 49 A17+C,<#W.1GC$)("'W"$$4-<.49B$#="#$=#AB6E'aM"#$52<=#
! W#"(::ML 3 "#$(),:X"$#="#$=#-.+I9<%JE= I9<52<W61)+/"*/CF,ED#"#$"$."$#="#$=#A*DB6$#="#$ 4M1'L+1G>)H>K.*<.+4M
-<.49B=#AB6E'aM"#$($'C#$=#:ML/"F(UE<5,8#,-<.49B /@$#6C#""$."$#="#$=#:MLU4D4M5,8#,-<.49B N%$A"$4W6U4D.,3H#*5C<
(),:X"U7< C$K."#$"$."E'aM"#$($'C#$=#:MLU4D9"*<.+ N%$A"$4W6U4D1#4#$>G,E?%$'4#?/4F7=#:MLI9<%JE=52<5,A*DB6E),U7<5,
(:,M;W6"BD#EX+E'aM"#$/@'L4-<.49B$#="#$=# AB6"#$/@'L4E'aM"#$($'C#$=# 5,"$?M:MLU4D4M-<.49B ZXL+I9<52<1#4#$:GU7< 7)+,M;
1. 3$+:H6I8>#;8A2+$93$+9$
$9%:ML 50 A17+C,<#W."#$/@'L4-<.49B$#="#$=#AB6E'aM"#$/BK.""B3D4=#
31
!""#$ 5 8*2-9:'&>%&'>&!:#=BCD%&'()*>&
2
1
2

! -);,*.,"#$/@'L4-<.49B$#="#$=#
1. /4KL./-<#19DC,<#W."'W"$$4-<.49B$#="#$=#AB6E'aM"#$52<=#AB<E 5C</BK."A($#="#$ “9$D@"*J77)K&"” 7)+$9%:ML 50
2. /BK.""B3D4=#1GC$)($#="#$=#:ML*<.+"#$/@'L45,2D.+ “MIMS Classiﬁcation” *)E.=D#+/2D, *<.+"#$/@'L4-<.49B
1GC$)(=#5,"B3D4 Dyslipidemia agents C$K. 1#4#$$6(3/%Q,$C)1"B3D4=# ZXL+$C)1-.+=#"B3D4,M;>K. 02L 7)+$9%:ML 50
$9%:ML 51 A17+C,<#W.$#="#$=#:ML9"(),:X"UE<5,8#,-<.49B-.+=#"B3D4 Dyslipidemia agents
3. "7 Enter N%$A"$4W6A17+$#="#$=#5,"B3D4 Dyslipidemia agents :ML/>=9"(),:X"UE< 7)+$9%:ML 51
4. I9<52<U4DWG/%Q,*<.+"$."-<.49B5C<>$(:3"2D.+ A*D2D.+:MLWG/%Q,*<.+$6(3>K. “2KL.=#.."P:a'gAB6>E#4A$+” N7=5C<"$."
2KL.=#AB6-,#7>E#4A$+-.+=#,);,f 7)+$9%:ML 51
5. >B'":ML%3J4 “K&"LM3” /@KL.:G"#$(),:X"-<.49B
6. I9<52<1#4#$="/B'""#$/@'L4C$K.A"<U--<.49B=#:ML"GB)+:G$#="#$.=9D N7=>B'":ML%3J4 “93:263”
! ! C4#=/C*3:! 1. "#$/@'L4-<.49B$#="#$=#,);, >E$A,D5WED#U4D4M-<.49B=#,);,.=9D5,8#,-<.49B.=9DAB<E /@$#6W6:G5C</"'7-<.49B
! ! ! ! $#="#$=#Z;GZ<.,U7<
! ! ! ! 2. C#"U4D4M>E#4WG/%Q, U4D>E$B(-<.49B$#="#$=# N7="#$>B'":ML%3J4 “B($#="#$” /@$#6W6:G5C<$C)1=#5,8#,
! ! ! ! -<.49B9"B(
2. 3$+:H6I8D2,D3#N>%6E<3$+K+6!$+9$
$9%:ML 52 A17+C,<#W."#$/@'L4-<.49B$#="#$=#AB6E'aM"#$/BK.""B3D4=#
!
32
!""#$ 5 8*2-9:'&>%&'>&!:#=BCD%&'()*>&
4
3
5
2
1
54
3
6

! -);,*.,"#$/@'L4AB6A"<U-E'aM"#$($'C#$=#
1. /4KL./-<#19DC,<#W."'W"$$4-<.49B$#="#$=#AB6E'aM"#$52<=#AB<E 5C</BK."A($#="#$ “3$+K+6!$+9$” 7)+$9%:ML 52
2. "$."-<.49B$C)1"#$($'C#$=#:ML*<.+"#$/@'L4/*'45,2D.+ “+!&-3$+K+6!$+9$” *#4/+KL.,U-:ML"GC,7 7)+$9%:ML 52
3. "$."-<.49B5,2D.+ “%6E<3$+K+6!$+9$DKK9O;” AB6 “%6E<3$+K+6!$+9$DKK:'P8” 7)+$9%:ML 52
4. "$."-<.49B5,2D.+ “7Q"%"9$'O;/+&?.” C4#=X+ *)E/B-WG,E,/4F7=#*D."#$52<A*DB6>$);+ 7)+$9%:ML 52
5. "$."-<.49B5,2D.+ “7Q"%"/+&?.'O;%&"” C4#=X+ *)E/B-WG,E,>$);+:ML52<=#*D.E), 7)+$9%:ML 52
6. N%$A"$4W6>G,E?WG,E,/4F7=#*D.E),5C<N7=.)*N,4)*' (U4D*<.+"$."5,2D.+ “7Q"%"9$'O;%&"”)
7. I9<52<1#4#$A"<U-E'aM"#$($'C#$=#U7< N7=@'4@R$C)1"#$($'C#$=#:ML*<.+"#$AB6:G"#$A"<U-*#4-);,*.,:ML 2 - 6
8. >B'":ML%3J4 “K&"LM3” /@KL.:G"#$(),:X"-<.49B
9. I9<52<1#4#$="/B'""#$/@'L4C$K.A"<U--<.49B=#:ML"GB)+:G$#="#$.=9D N7=>B'":ML%3J4 “93:263”
:.RI;"N>3$+-+#$.+!&-%6E<3$+K+6!$+9$
! $C)1E'aM"#$($'C#$=# %$6".(7<E=*)E/B-AB6*)E.)"O$WG,E, 4 237 7)+,M;
G)=L$);+ 5C<$6(3/%Q, “:2>7Q"%":'P8!+R;:S4-O%"”
/2D, C#"I9<%JE=$)(%$6:#,=#>$XL+/4F7 5C<$6(3/%Q, “1/2” C$K. I9<%JE=$)(%$6:#,=#/TO
C,XL+1DE,1ML 5C<$6(3/%Q, “1/4” /%Q,*<,
G)=L$);+-.+"#$$)(%$6:#,=#*D.E), 5C<$6(3/%Q, “:2>7Q"%":'P8”
/2D, !C#"I9<%JE=$)(%$6:#,=# E),B6 1 >$);+ 5C<$6(3/%Q, “1” C$K.I9<%JE=$)(%$6:#,=# E),
B6 3 >$);+ 5C<$6(3/%Q, “3” /%Q,*<,
G)=L<I 3.(*)E.)"O$)! C4#=X+! E'aM"#$$)(%$6:#,=#:ML1)4@),aR")(4K;..#C#$ C$K."D.,,., N7=$6(3/%Q, “'&%;&34+9O;
T+8&"”
/2D,! C#"I9<%JE=$)(%$6:#,=#"D.,.#C#$ 5C<$6(3/%Q, “ac”, I9<%JE=$)(%$6:#,=#CB)+
.#C#$ 5C<$6(3/%Q, “pc” C$K.I9<%JE=$)(%$6:#,=#"D.,,., 5C<$6(3/%Q, “hs”
G)=L<I 4.(*)E/B-)! C4#=X+! /EB#:MLI9<%JE=$)(%$6:#,=# ZXL+A:,:MLN7=*)E/B- 1 – 4 7)+,M;
C4#=/B- 1! C4#=X+! /EB#/2<# C$K. 4K;./2<#
C4#=/B- 2! C4#=X+! /EB#"B#+E), C$K. 4K;./:ML=+
C4#=/B- 3! C4#=X+! /EB#/=F, C$K. 4K;./=F,
C4#=/B- 4! C4#=X+! /EB#"D.,,.,
'&%;9O$.3$+-+#$.%6E<3$+K+6!$+9$
U '&%;9O$.L$);+ >K. >$ML+/4F7 ! 7)+,);,*)E/B-237:ML 1 >K.! “ 1/2 ”
G)=L$);+-.+"#$$)(%$6:#,=#*D.E), >K. 2 >$);+! 7)+,);,*)E/B-237:ML 2 >K.! “ 2 ”
G)=LK. CB)+.#C#$! 7)+,);,*)E.)"O$237:ML 3 >K.! “ pc “
G)=LK. /2<# /=F,! 7)+,);,7)E/B-237:ML 4 >K.! “ 13 “
7)+,);,"#$"$."E'aM"#$($'C#$=#5,N%$A"$4W64MB)"O?67)+,M;
! “$C)1"#$($'C#$=#”! >K.! 1/22pc13
! “E'aM"#$($'C#$=#A((=D.”! >K.! 2x2 pc /2<# /=F,
! “E'aM"#$($'C#$=#A((/*F4”! >K.! $)(%$6:#,>$);+B6 1/2 /4F7 E),B6 2 >$);+ CB)+.#C#$ /2<# /=F,
! “WG,E,/4F7=#*D.>$);+”! >K.! 1/2
! “WG,E,>$);+*D.E),”! >K.! 2
33
!""#$ 5 8*2-9:'&>%&'>&!:#=BCD%&'()*>&

'&%;9O$.LK.
! ! ! -O%"L<I 1: “+&K*+,L$"9$/+&?.2, 2 :8P= 3O;";$!$+ :G#$ 32$.%&"”
! ! ! -O%"L$);+ >K. 2 /4F7 ! 7)+,);,*)E/B-237:ML 1 >K.! “ 2 ”
G)=L$);+-.+"#$$)(%$6:#,=#*D.E), >K. 2 >$);+ ! 7)+,);,*)E/B-237:ML 2 >K.! “ 2 ”
G)=LK. "D.,.#C#$! 7)+,);,*)E.)"O$237:ML 3 >K.! “ ac “
G)=LK. /2<# "B#+E),! 7)+,);,7)E/B-237:ML 4 >K.! “ 12 “
U -O%"L$);+ >K. 1 /4F7 ! 7)+,);,*)E/B-237:ML 1 >K.! “ 1 ”
G)=L$);+-.+"#$$)(%$6:#,=#*D.E), >K. 1 >$);+ ! 7)+,);,*)E/B-237:ML 2 >K.! “ 1 ”
G)=LK. "D.,.#C#$! 7)+,);,*)E.)"O$237:ML 3 >K.! “ ac “
G)=LK. /=F,! 7)+,);,7)E/B-237:ML 4 >K.! “ 3 “
7)+,);,"#$"$."E'aM"#$($'C#$=#5,N%$A"$4W64MB)"O?67)+,M;
! “$C)1"#$($'C#$=#”! >K.! 22ac1211ac3 ($E41DE,:ML 1 AB61DE,:ML 2)
! “E'aM"#$($'C#$=#A((=D.”! >K.! 2x2 ac /2<# "B#+E), 1x1 ac /=F,
! “E'aM"#$($'C#$=#A((/*F4”! >K.! $)(%$6:#,>$);+B6 2 /4F7 "D.,.#C#$ /2<# "B#+E), AB6>$);+B6 1 /4F7 "D.,
.#C#$/=F,
! “WG,E,/4F7=#*D.>$);+”! >K.! 1.67
! “WG,E,>$);+*D.E),”! >K.! 3
34
!""#$ 5 8*2-9:'&>%&'>&!:#=BCD%&'()*>&

คู่มือการใช้โปรแกรม Pharmacy MTM

Recomendados

Recomendados

Mais conteúdo relacionado

Mais procurados

Mais procurados (19)

Semelhante a คู่มือการใช้โปรแกรม Pharmacy MTM

Semelhante a คู่มือการใช้โปรแกรม Pharmacy MTM (20)

คู่มือการใช้โปรแกรม Pharmacy MTM